As of May 2024 Twist Bioscience has a market cap of $2.38 Billion. This makes Twist Bioscience the world's 3845th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.38 B | 12.08% |
2023 | $2.12 B | 57.83% |
2022 | $1.34 B | -65.7% |
2021 | $3.92 B | -42.4% |
2020 | $6.81 B | 875.84% |
2019 | $0.69 B | 7.99% |
2018 | $0.64 B |
On May 3rd, 2024 the market cap of Twist Bioscience was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $11.73 M | -99.51% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -84.05% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | -70.95% | ๐บ๐ธ USA |
Novocure
NVCR | $1.59 B | -33.25% | Jersey |